January 1, 2017, marks the beginning of a new way of being paid in Medicare. And while the final rule of MACRA was released in October, and many providers and practices are still trying to parse out what it will mean to them.
January 1, 2017, marks the beginning of a new way of being paid in Medicare. The Medicare Access and CHIP Reauthorization Act (MACRA) was 1 of a just a few examples of healthcare policy that has enjoyed overwhelming bipartisan support in recent years. MACRA replaces the controversial and problematic sustainable growth rate formula with a new way to adjust payments to providers.
While 2017 is the start of the law's implementation, it is being viewed as a transition year. Simply participating and submitting quality data prevents providers from receiving a negative payment adjustment.
The final rule of MACRA was released in October, and many providers and practices are still trying to parse out what it will mean to them. See the below infographic for a look at what MACRA means and how payment will be affected.
Health Equity & Access Weekly Roundup: November 23, 2024
November 23rd 2024Americans are underinsured, even with employer-based health plans; a thorough critique of the lack of representation among Black patients in clinical trials showcases a persistent theme; systemic barriers in cardiology, breast cancer, and patent systems are examined.
Read More
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen